Harnessing mesenchymal stem cell homing as an anticancer therapy (Q38857484)

7 September 2017

1 reference

title

Harnessing mesenchymal stem cell homing as an anticancer therapy (English)

1 reference

7 September 2017

mesenchymal stem cell

1 reference

6

Christine Spitzweg

1 reference

7 September 2017

Anna Hagenhoff

1

1 reference

7 September 2017

Christiane J Bruns

2

1 reference

7 September 2017

Yue Zhao

3

1 reference

7 September 2017

Irene von Lüttichau

4

1 reference

7 September 2017

Hanno Niess

5

1 reference

7 September 2017

Peter J Nelson

7

1 reference

7 September 2017

language of work or name

English

0 references

publication date

8 June 2016

1 reference

Expert Opinion on Biological Therapy

7 September 2017

1 reference

7 September 2017

16

1 reference

7 September 2017

9

1 reference

7 September 2017

1079-1092

1 reference

Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment.

7 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Adult human adipose tissue contains several types of multipotent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells: Molecular characteristics and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: adult multipotent stromal cells and cancer: risk or benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells: Mechanisms of immunomodulation and homing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: role of mesenchymal stem cells in wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stem Cells in Chronic Wounds: The Spectrum from Basic to Advanced Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Role of stem/progenitor cells in reparative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Tumor microenvironment: bone marrow-mesenchymal stem cells as key players

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Bone marrow-derived mesenchymal stem cells and the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

One cell, multiple roles: contribution of mesenchymal stem cells to tumor development in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells: flip side of the coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Paracrine mechanisms in adult stem cell signaling and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Bone marrow-derived mesenchymal stem cells promote growth and angiogenesis of breast and prostate tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell secretome and regenerative therapy after cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human Adipose Tissue-Derived Mesenchymal Stem Cells Target Brain Tumor-Initiating Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeted inhibition of osteosarcoma tumor growth by bone marrow-derived mesenchymal stem cells expressing cytosine deaminase/5-fluorocytosine in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Getting to the site of inflammation: the leukocyte adhesion cascade updated

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Recent advances into the understanding of mesenchymal stem cell trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Homing of progenitor cells to ischemic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells exhibit firm adhesion, crawling, spreading and transmigration across aortic endothelial cells: effects of chemokines and shear

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Towards in situ tissue repair: human mesenchymal stem cells express chemokine receptors CXCR1, CXCR2 and CCR2, and migrate upon stimulation with CXCL8 but not CCL2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Macrophage migration inhibitory factor-CXCR4 is the dominant chemotactic axis in human mesenchymal stem cell recruitment to tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Regulation of the chemokine receptor CXCR4 by hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal cell interaction with ovarian cancer cells induces a background dependent pro-metastatic transcriptomic profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeting tumor-stromal interactions in bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Bone marrow cells in the 'pre-metastatic niche': within bone and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The fibroblast: sentinel cell and local immune modulator in tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TGF-beta in CAF-mediated tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Immunosuppressive mechanisms of human bone marrow derived mesenchymal stromal cells in BALB/c host graft versus host disease murine models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mechanisms of tumor escape from immune system: role of mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Inflammatory chemokines and metastasis--tracing the accessory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

PGE2 contributes to in vitro MSC-mediated inhibition of non-specific and antigen-specific T cell proliferation in MS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Cord blood mesenchymal stem cells suppress DC-T Cell proliferation via prostaglandin B2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The immunosuppressive properties of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stromal cells are more effective than the MSC secretome in diminishing injury and enhancing recovery following ventilator-induced lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Immunomodulatory properties of mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Genetically engineered stem cells for therapeutic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Stem cell based cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cells engineered for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Exploitation of stem cell homing for gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Cell-based drug-delivery platforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

A tumor-selective biotherapy with prolonged impact on established metastases based on cytokine gene-engineered MSCs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapy with Multipotent Mesenchymal Stromal Cells Protects Lungs from Radiation-Induced Injury and Reduces the Risk of Lung Metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Intratracheal delivery of CX3CL1-expressing mesenchymal stem cells to multiple lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TRAIL-transduced multipotent mesenchymal stromal cells (TRAIL-MSC) overcome TRAIL resistance in selected CRC cell lines in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Suppression of orthotopically implanted hepatocarcinoma in mice by umbilical cord-derived mesenchymal stem cells with sTRAIL gene expression driven by AFP promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

HSV-tk expressing mesenchymal stem cells exert bystander effect on human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Treatment of advanced gastrointestinal tumors with genetically modified autologous mesenchymal stromal cells (TREAT-ME1): study protocol of a phase I/II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Linking transgene expression of engineered mesenchymal stem cells and angiopoietin-1-induced differentiation to target cancer angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stem Cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Image-guided, tumor stroma-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated NIS gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Inducible release of TRAIL fusion proteins from a proapoptotic form for tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Gene-directed enzyme prodrug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Influence of the bystander effect on HSV-tk/GCV gene therapy. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The Anti-Tumor Effects of Adipose Tissue Mesenchymal Stem Cell Transduced with HSV-Tk Gene on U-87-Driven Brain Tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Noninvasive theranostic imaging of HSV-TK/GCV suicide gene therapy in liver cancer by folate-targeted quantum dot-based liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

[(11)C]FMAU and [(18)F]FHPG as PET tracers for herpes simplex virus thymidine kinase enzyme activity and human cytomegalovirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Biodistribution, PET, and radiation dosimetry estimates of HSV-tk gene expression imaging agent 1-(2'-Deoxy-2'-18F-Fluoro-beta-D-arabinofuranosyl)-5-iodouracil in normal dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Human mesenchymal stem cells provide protection against radiation-induced liver injury by antioxidative process, vasculature protection, hepatocyte differentiation, and trophic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Radiation increases invasion of gene-modified mesenchymal stem cells into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

TNF-α respecifies human mesenchymal stem cells to a neural fate and promotes migration toward experimental glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Effects of human epidermal growth factor gene-transfected mesenchymal stem cells on fibroblast migration and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Basic fibroblast growth factor controls migration in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

21 January 2018

Engineered cell homing

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Cell surface engineering of mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mimicking the inflammatory cell adhesion cascade by nucleic acid aptamer programmed cell-cell interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The inflammatory chemokine CCL5 and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The sodium iodide symporter: its pathophysiological and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

The biology of the sodium iodide symporter and its potential for targeted gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Systemic image-guided liver cancer radiovirotherapy using dendrimer-coated adenovirus encoding the sodium iodide symporter as theranostic gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Gene therapy in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: an exploratory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Epidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Detection of spontaneous tumorigenic transformation during culture expansion of human mesenchymal stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Emergence of clonal chromosomal alterations during the mesenchymal stromal cell cultivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal stem cell adhesion to cardiac microvascular endothelium: activators and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Mesenchymal Stem Cells: Potential Precursors for Tumor Stroma and Targeted-Delivery Vehicles for Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

Metastasis: The rude awakening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14712598.2016.1196179

10.1080/14712598.2016.1196179

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference